unknown
Stage
3
Investors
About
Curetis GmbH offers the Unyvero A50 rapid molecular diagnostic solution for severe infections, providing broad coverage of pathogens and resistance markers and delivering results in under 5 hours with minimal hands-on time.
Explore Curetis, Germany's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.